Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.40 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.37 |
| ▸ | GPR3 | P46089 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 2/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 2/20 | 0.34 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.32 |
| ▸ | MPO | P05164 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
| ▸ | DAO | P14920 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17028761 | 0.86 | GPR3 (0.38) | TAAR1AOC3GPR3MAOBMAOA | |
| SCHEMBL17028760 | 0.86 | GPR3 (0.38) | TAAR1AOC3GPR3MAOBMAOA | |
| SCHEMBL620590 | 0.86 | GPR3 (0.38) | TAAR1AOC3GPR3MAOBMAOA | |
| SCHEMBL20399306 | 0.78 | GPR3 (0.39) | TAAR1GPR3HPGD | |
| SCHEMBL20399308 | 0.78 | GPR3 (0.39) | TAAR1GPR3HPGD | |
| SCHEMBL20399307 | 0.78 | GPR3 (0.39) | TAAR1GPR3HPGD | |
| SCHEMBL26631641 | 0.78 | GPR3 (0.39) | TAAR1GPR3HPGD | |
| SCHEMBL1441308 | 0.77 | ALDH1A1 (0.38) | MEN1KMT2A | |
| SCHEMBL15994994 | 0.77 | RIPK1 (0.35) | GPR3RIPK1 | |
| SCHEMBL15994995 | 0.77 | RIPK1 (0.35) | GPR3RIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011138293-A1 | 2,5,6,7-TETRAHYDRO-[1,4]OXAZEPIN-3-YLAMINE OR 2,3,6,7-TETRAHYDRO-[1,4]OXAZEPIN-5-YLAMINE COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2011-11-10 | — | — | WO | disclosed |